Government ❯Regulation

Drug Approval

Drug Approval Health Equity HIV/AIDS FDA Approval Infectious Diseases Cost Analysis Clinical Trials Drug Pricing

FDA to Decide on Twice-Yearly HIV Preventive Drug Lenacapavir

Generic manufacturers are set to produce lenacapavir for as little as $25 per patient annually